PAR paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-7

  1. 905 Posts.
    lightbulb Created with Sketch. 209
    $24mill in the bank account Dec 31, 2025.

    $12mill spend expected this quarter leaves $12mill to get through June quarter. The report tends to suggest that they are going to conserve cash by delaying the USA recruitment to the 2nd half of CY.

    No update regarding future partnerships or finance.

    I think this quarterly will put a dampener on the share price a little.





    Last edited by MixedBag: 30/01/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
39.0¢
Change
-0.010(2.50%)
Mkt cap ! $154.9M
Open High Low Value Volume
39.0¢ 40.0¢ 38.5¢ $209.9K 536.5K

Buyers (Bids)

No. Vol. Price($)
2 51648 39.0¢
 

Sellers (Offers)

Price($) Vol. No.
39.5¢ 45413 11
View Market Depth
Last trade - 14.31pm 30/07/2025 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.